S
Santhera Pharmaceuticals Holding AG (SPHDF)
PNK – Real vaqt narxi. Valyuta: USD
23.25
0.00 (0.00%)
Yopilishda: Sep 4, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
PNK – Real vaqt narxi. Valyuta: USD
23.25
0.00 (0.00%)
Yopilishda: Sep 4, 2026, 4:00 PM EDT
Santhera Pharmaceuticals Holding AG, ixtisoslashgan farmatsevtika kompaniyasi, o'zining sho'ba korxonalari bilan birgalikda Yevropa, Shimoliy Amerika va Osiyoda yuqori tibbiy ehtiyojni qondira olmagan kam uchraydigan neuromuskulyar va o'pka kasalliklari uchun dori vositalarini ishlab chiqadi va sotadi. Kompaniyaning yetakchi quvur liniyasi nomzodi Vamorolone hisoblanadi, u Duchenne mushak distrofiyasini davolash uchun ishlab chiqilmoqda. Santhera Pharmaceuticals Holding AG 2004 yilda tashkil etilgan va Shveytsariyaning Pratteln shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Oliver P. Kronenberg Ph.D. | Chief Legal Officer & Corporate Secretary |
| Dr. Shabir Hasham M.D. | Chief Medical Officer |
| Dr. Thomas Meier Ph.D. | Founder & Chairman |
| Mr. Andreas Missy | Executive Vice President of Corporate Planning & Business Development |
| Mr. Marc Schrader | Chief Technology Officer |
| Mr. Neville Kodkani M.D. | Head of Global Marketing & Partner Management |
There is no data to display
| Mr. Oliver Strub |
| Head of Compliance |
| Mr. Orlando Oliveira | Chief Executive Officer |
| Ms. Catherine Ann Isted A.C.M.A. | Chief Financial Officer |
| Ms. Sarah Holmes-Klotz | Global Head of People & Culture |